Silent Disease Boosts Heart & Cancer Death Risk by 50%
- A widespread,often undetected condition can double the risk of death from cardiovascular or oncological causes.
- A study published in The Journal of Hepatology analyzed data from more than 13,000 patients in Sweden diagnosed with MASLD between 2002 and 2020.
- Furthermore, individuals with MASLD had a 27-fold higher risk of death from liver disease and a 35-fold higher risk of developing liver cancer.
Silent Liver Disease Linked to Increased Risk of Death
Table of Contents
A widespread,often undetected condition can double the risk of death from cardiovascular or oncological causes. Fatty liver disease, specifically steatotic hepatic disease associated with metabolic dysfunction (MASLD), is more common among individuals who are overweight or obese.
The link between MASLD and Mortality
A study published in The Journal of Hepatology analyzed data from more than 13,000 patients in Sweden diagnosed with MASLD between 2002 and 2020. the study found that these patients faced nearly double the mortality risk compared to the general population. Cardiovascular disease and non-hepatic cancers were the most frequent causes of death, with mortality rates increasing by 54% and 47%, respectively.
Furthermore, individuals with MASLD had a 27-fold higher risk of death from liver disease and a 35-fold higher risk of developing liver cancer. Researchers also noted increased mortality rates related to infections, gastrointestinal diseases, respiratory illnesses, and endocrine disorders.
Symptoms and Risk Factors
MASLD is considered dangerous because it often presents no obvious symptoms in its early stages. The condition arises from the accumulation of fat in the liver, possibly leading to fibrosis, cirrhosis, or even liver failure over time. According to the NHS, several factors can increase the risk of developing MASLD:
- Age over 50
- Insulin resistance (e.g., polycystic ovary syndrome)
- High blood pressure
- Hypothyroidism
- Obesity, especially excess abdominal fat
- Type 2 diabetes
- Smoking
- High cholesterol
- Metabolic syndrome (a combination of diabetes, hypertension, and obesity)
When Symptoms Appear
Symptoms typically manifest in the advanced stages of the disease, when the liver is affected by cirrhosis.These symptoms may include:
- Chronic fatigue
- Itching skin
- Yellowing of the skin and eyes (jaundice)
- Swelling of the abdomen and extremities
- Unexplained weight loss
- Bleeding or easy bruising
- Confusion and difficulty concentrating
If these symptoms arise,seeking immediate medical attention is crucial.
The Importance of Complete Treatment
Experts emphasize the need for multidisciplinary treatment for MASLD patients.
We should not focus only on the liver, but adopt a holistic approach, involving several medical specialties.
Dr. Hannes Hagström,co-author of the study
Early detection and lifestyle modifications,such as a balanced diet,regular physical activity,and smoking cessation,are essential in preventing disease progression and reducing associated risks.
Silent Liver Disease: Understanding the Risks and Taking Action
What is Silent Liver Disease? (MASLD)
Silent liver disease, also known as steatotic hepatic disease associated with metabolic dysfunction (MASLD), is a condition characterized by fat accumulation in the liver. It is often undetected in its early stages, making it a hazardous condition. MASLD is more common in individuals who are overweight or obese.
How Does MASLD Increase the Risk of Death?
A study published in The Journal of Hepatology found that individuals with MASLD face nearly double the mortality risk compared to the general population. This means people with MASLD have a significantly higher chance of dying from various causes.
What are the Main Causes of death Associated with MASLD?
The study revealed that cardiovascular disease and non-hepatic cancers are the most frequent causes of death in patients with MASLD. Specifically:
Mortality rates for cardiovascular disease increased by 54%.
Mortality rates for non-hepatic cancers increased by 47%.
Furthermore, individuals with MASLD had a:
27-fold higher risk of death from liver disease.
35-fold higher risk of developing liver cancer.
increased mortality rates were also noted related to infections, gastrointestinal diseases, respiratory illnesses, and endocrine disorders.
What are the Risk Factors for Developing MASLD?
Several factors can increase your risk of developing MASLD. The NHS has identified the following risk factors:
Age over 50
Insulin resistance (e.g., polycystic ovary syndrome)
High blood pressure
Hypothyroidism
Obesity, especially excess abdominal fat
Type 2 diabetes
smoking
High cholesterol
Metabolic syndrome (a combination of diabetes, hypertension, and obesity)
What are the Symptoms of MASLD?
In its early stages, MASLD often presents no obvious symptoms. However, symptoms typically manifest in the advanced stages when the liver is affected by cirrhosis. These symptoms include:
Chronic fatigue
Itching skin
Yellowing of the skin and eyes (jaundice)
Swelling of the abdomen and extremities
Unexplained weight loss
Bleeding or easy bruising
Confusion and difficulty concentrating
If you experience these symptoms, seeking immediate medical attention is crucial.
How is MASLD Treated?
Experts emphasize the need for multidisciplinary treatment for MASLD patients. Early detection and lifestyle modifications are essential. This includes a balanced diet,regular physical activity,and smoking cessation to prevent disease progression and reduce associated risks. According to Dr. Hannes Hagström, co-author of the study, a holistic approach is necessary involving several medical specialties.
Understanding the Risks: A Summary
Below is a table summarizing key details about the increased risks associated with MASLD, based on the provided information.
| Risk Factor | Increased Risk |
| ————————— | —————————————————— |
| Overall Mortality | Nearly double the risk compared to the general population |
| Cardiovascular disease | 54% increase in mortality rate |
| Non-Hepatic Cancers | 47% increase in mortality rate |
| Liver Disease | 27-fold higher risk of death |
| Liver Cancer | 35-fold higher risk |